The relationship between serum ascorbic acid (AA) and diabetic macroangiopathy was studied. Fifty-six patients with non insulin-dependent diabetes mellitus were examined, together with 20 healthy controls matched for age against the diabetes patients. Aortic pulse wave velocity (PWV) was taken as an index of the severity of ather osclerosis. The level of serum AA in diabetic patients was significantly lower than that of the controls. Among the diabetic groups, those with elevated PWV levels by age demonstrated a significant drop in AA. No significant differences were seen in the level of serum dehydroascrobic acid (DHAA) between patients and controls, nor were there any signifi cant differences among patient groups. The concentration of serum AA was inversely related to the risk factors of atherosclerosis, such as body mass index, Apo B/Apo A-I ratio, thiobarbituric acid-reactive substances (TBARS), and microalbumin in urine. It was inferred from these findings that the depletion of serum AA was apparent in diabetics with advanced atherosclerosis.
proteins in the presence of a high blood glucose concentration (6) (7) (8) , and the glycation of Cu and Zn-superoxide dismutase (SOD) lowers SOD activity (9) .
Organisms defend against the free radical-LPO system with enzymes, proteins, and vitamins. Of all these compounds, ascorbic acid (AA) is a powerful antioxi dant in aqueous solution (10) and in human plasma (11) . Fat-soluble vitamin E is a powerful antioxidant in the cell membrane or lipoprotein, and it is known that the byproduct generated by the antioxidative reaction, a vitamin E radical, is reduced by aqueous AA to reconstruct vitamin E (12) (13) (14) . The same kind of reaction is observed with human low-density lipoprotein (LDL) (15) . Furthermore, the synthesis of collagen and proteoglycans decreases when the intake of AA in cells is restricted in the fibroblast culture system with high blood glucose concentrations (16) . This finding suggests that cytotoxically damaged vascular endothelium can be caused by an abnormality in collagen synthesis under the conditions of AA deficiency. The present study examined the effect of serum AA and dehydroascor bic acid (DHAA) on diabetic macroangiopathy. 
RESULTS
When compared to grups A, B, and C, the frequency of hypertension in group D was higher. The frequency of retinopathy in groups C and D was significantly higher than that in group A ( Table 1) .
The concentration of FBG in group D was higher than that in group A, and the HbA1c level in group D was higher than that in group A (Table 2 ). There were no marked differences in the amount of TC, TG, HDL-C, or the atherogenic index among diabetic groups. The serum TBARS levels in group D was significantly higher than that in normal subjects. AA, ascorbic acid; DHAA, dehydroascorbic acid; LIPWV, the difference between the mean PWV of healthy subjects and the PWV of patients of the same age. *p<0.05. PWV testing, which is non-invasive, was used in this study to determine the severity of atherosclerosis. Patients with a high PWV value had a higher frequency of hypertension and retinopathy. Similar results were also reported by Hara et al. (20) .
Numerous reports have found decreased levels of AA in diabetics (21) (22) (23) (24) (25) , and similar results were obtained in the present study. Also, numerous cases showing reduced AA concentration inside the cells of diabetics with a high blood glucose level have been reported (22, (26) (27) (28) (29) (30) . DHAA, the oxidized form of AA, is quickly taken up by the cell (31, 32) , and is instantly reduced to AA, inside the cell. Since glucose and AA share the same transport molecule on the cell membrane, the uptake of AA is impeded by glucose (28) . The number of transporters on the membrane increases in the presence of insulin, and is reduced in diabetic patients (22) . When foods containing AA are ingested by diabetic patients, the amount of AA that exceeds the excretion threshold of the kidneys is excreted into the urine because of the reduced uptake ability of AA in cells. However, we could not show an inverse relationship between the amount of serum AA and FBG or HbA1c in this study. For this reason, diabetic patients with marked lowering of the serum AA concentration were included considerably among them unrelated to glucose level. It was suggested that the depletion of AA was associated with diabetes and this was especially true in patients with advanced atherosclerosis, because reduced amounts of AA were observed in patients with decreased PWV values. The present study failed to take into account the lack of vitamin C intake, which might cause a decrease in the level of serum AA. However, the BMIs of the diabetic patients were higher than those of the controls, and none of the diabetic patients were on a restricted diet. A study conducted in Massachusetts reported that insulin dependent diabetes mellitus patients were consuming adequate dietary vitamin C (30) . This finding argues against the idea that the lack of vitamin C in the diet causes a decrease in the amount of serum AA.
Because of the oxidative nature of the disease, an increase in the amount of DHAA or elevation of the DHAA/AA ratio was predicted in diabetic patients before this study. However, no significant difference was observed between the patients and controls. Nevertheless, one report stated that the DHAA/AA ratio was higher in diabetics than in normal subjects (25) . This may have been due to differences between the group of diabetic patients in the present study and previous reports, or possibly due to differences in the time when blood was collected. It can reasonably assumed that DHAA should not be used as an indicator of oxidation because: 1) DHAA is reduced by DHAA reductase and also reduced non enzymatically by a thiol complex such as cysteine or glutathione and 2) DHAA is easily and irreversibly converted to 2, 3-diketogulonic acid by cleavage of the lactone ring.
AA has been reported to be a potent free radical scavenger in aqueous solution (10, 11) , and is known to block the oxidation of LDL (33) . Furthermore, several studies have shown that AA acts synergistically with vitamin E to block the oxidation of lipids in the cell membrane by exchanging a radical with a tocopher oxyl radical (12-15, 34, 35) . This kind of relationship is also observed in human LDL (15) . An oxidation test in the plasma using azo chemical compounds showed that, of all radical scavengers, AA is consumed the fastest (11) . Because of the oxidative nature of the disease, it is suggested that AA is overly consumed in diabetic patients, and the reduced level of AA might lead to the development of atherosclerosis.
In addition, a decrease in the level of AA causes disruption of collagen synthesis (16, 24) , and might cause cytotoxic damage in vascular endothelium. Also, AA acts as an aldose reductase inhibitor (36) (37) (38) and blocks the polyol pathway, which might slow the development of atherosclerosis.
In conclusion, our results show that the depletion of AA is observed in patients with advanced diabetic macroangiopathy.
